-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342

Benzinga·11/02/2026 19:58:03
Diffusion vocale
Leerink Partners analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $309 to $342.